Skip to main content
HeartCited

Nattokinase 관련 고혈압

C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.

Modest BP reduction (systolic -3.5 mmHg). Fibrinolytic mechanism may contribute to vascular effects. Larger confirmatory trials are needed.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnattokinase\u0026condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
결론

            
            
Modest BP reduction (systolic -3.5 mmHg). Fibrinolytic mechanism may contribute to vascular effects. Larger confirmatory trials are needed.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                효과: None
                
                
                None
                
            

            
            
대상 집단: Review of anti-atherosclerotic supplements and bleeding

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
6

        
연구

    

    

        
400

        
참여자

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
등급

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        International journal of …
                        2025
                        
                        1 인용
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
일반적으로 사용되는 용량

                

                    
                    

                        
general:

                        
2,000 FU (fibrinolytic units)/day

                    

                    
                    

                        
cardiovascularsupport:

                        
2,000-4,000 FU/day

                    

                    
                

                
                

                    상한량: Not formally established; up to 10,800 FU/day used in clinical trials
                

                
            

            

            
            

                
연구에서 사용된 용량

                

                    

                        
                            

                                용량
                                기간
                                효과
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                권장 복용 시간: On empty stomach (between meals) for optimal fibrinolytic activity
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
보고된 부작용

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Increased bleeding risk (fibrinolytic activity)
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Bruising (rare)
                        
    • 
                        
                    

                

                

                
                

                    
알려진 상호작용

                    
    
                        
                        
  • 
                            ●
                            Anticoagulants — warfarin, DOACs (additive anticoagulant effects — contraindicated)
                        
    • 
                        
                        
  • 
                            ●
                            Antiplatelet drugs (additive bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            NSAIDs (increased bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Fish oil at high doses (additive anticoagulant effect)
                        
    • 
                        
                    

                

                

                
                

                    

                        일일 최대 섭취 허용량: Not formally established; up to 10,800 FU/day used in clinical trials
                    

                

                
            

            

                건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Nattokinase help with 고혈압?
            
        
        

            Based on 6 studies with 400 participants, there is limited but promising evidence that Nattokinase may support 고혈압 management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Nattokinase should I take for 고혈압?
            
        
        

            Studies have used various dosages. A commonly studied range is 2,000 FU (fibrinolytic units)/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Nattokinase?
            
        
        

            Reported side effects may include Generally well-tolerated, Increased bleeding risk (fibrinolytic activity), Mild gastrointestinal discomfort, Bruising (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Nattokinase and 고혈압?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                
                

                
                

                    
Nattokinase 다른 건강 상태에 대한 근거

                    

                        
                        
                            동맥경화증
                            B

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Maria-Zinaida Dobre et al..
      Int J Mol Sci.
      2025.
      Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
      doi:10.3390/ijms262010183
      PubMed
    
    2. 
    
  















    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.